# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001213900-25-033326
Filing Date
2025-04-18
Accepted
2025-04-18 15:10:13
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0237916-03.pdf | ARS | 1087296
| Complete submission text file | 0001213900-25-033326.txt |  | 1499001

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-22873 | Film No.: 25850281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)